U.S. Markets closed

Agios Pharmaceuticals (AGIO) in Focus: Stock Rises 14.5%

Zacks Equity Research

Agios Pharmaceuticals, Inc. (AGIO) was a big mover last session, as its shares rose roughly 15% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the volatile price range of $68.25 to $86.87 in the past one-month time frame.

Over the last 30 days, this biopharmaceutical company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

Agios Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Other better-ranked stocks in the med products industry include OraSure Technologies, Inc. (OSUR), ICU Medical, Inc. (ICUI) and GW Pharmaceuticals plc (GWPH). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



ORASURE TECHNOLOGIES INC (OSUR): Free Stock Analysis Report

ICU MEDICAL INC (ICUI): Free Stock Analysis Report

GW PHARMACEUTICALS PLC ADS (GWPH): Free Stock Analysis Report

AGIOS PHARMACEUTICALS INC (AGIO): Free Stock Analysis Report


Zacks Investment Research